Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening

Journal of the National Medical Association

Volumn 98, Issue 1, 2006, Pages 51-57

  Theuer, Charles P ^a,c,d   Taylor, Thomas H ^a,c   Brewster, Wendy R ^a,b,c   Anton Culver, Hoda ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Colorectal cancer; Cost effectiveness; Race ethnicity; Screening

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASIAN; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; ETHNOLOGY; FEMALE; GENDER; HEALTH PROGRAM; HIGH RISK POPULATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; OCCULT BLOOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE; UNITED STATES;

AGED; AGED, 80 AND OVER; CALIFORNIA; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MASS SCREENING; MIDDLE AGED; POISSON DISTRIBUTION; REGISTRIES; SURVIVAL ANALYSIS;

EID: 30444452344     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004:54:8-29.
2. Selby JV, Friedman GD, Quesenberry CP Jr, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
3. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343: 1603-1607.
4. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311-1318.
5. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977-1981.
6. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1471.
7. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
8. Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case-control study of 32,702 veterans. Ann Intern Med. 1995;123:904-910.
9. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
10. Eddy D. Guidelines for the cancer-related checkup: recommendations and rationale. CA Ca J Clin. 1980;30:3-50.
11. Byers T, Levin B, Rothenberger D, et al. American Cancer Society Guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. CA Ca J Clin. 1997;47:154-160.
12. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Ca J Clin. 2001;51:38-75.
13. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.
14. Theuer CP, Wagner JL, Taylor TH, et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001;120:848-856.
15. Wu XC, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer. 2001;92:2547-2554.
16. Saltzstein SL, Behling CA. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer. 1998;82:1408-1410.
17. SEER Cancer Incidence Public-Use Database, 1973-1999. US Department of Health and Human Services, National Cancer Institute, Cancer Statistics Branch, Suite 504; MSC 8316; 6116 Executive Blvd., Bethesda, MD 20892-8316.
18. Chen VW, Fenoglio-Preiser CM, Wu XC, et al. Aggressiveness of colon carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1997;6: 1087-1093.
19. Centers for Disease Control and Prevention/National Center for Health Statistics. U.S. Decennial Life Tables for 1989-1991. Vol. II: state lifetables numbers, California, 1998.
20. California Tumor Registry. Cancer reporting in California: vol. 1, abstracting and coding procedures for hospitals. Emeryville, CA: Department of Health Services, Cancer Surveillance Section, 1986.
21. Seiffert JE, Price WT, Gordon B. The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry. Topics in Health Record Management. 1990;11:59-73.
22. Halvorson GW. Data standards and quality control regional registry quarterly submission status reports. Sacramento, CA: California Cancer Registry, May, 2000.
23. World Health Organization. ICD-O: International Classification for Diseases-Oncology. Edition 2. Geneva: World Health Organization, 1990.
24. U.S. Office of Technology Assessment. Cost and effectiveness of colorectal cancer screening in the elderly: background paper, publication BP-H-74, Washington, DC: U.S. Government Printing Office, 1990.
25. United States Office of Technology Assessment. Cost and effectiveness of colorectal cancer screening average-risk adults. Washington DC: U.S. Government Printing Office, 1995.
26. Wagner JL, Herdman RC, Wadhwa S. Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991;115:807-817.
27. Wagner JL, Tunis S, Brown M, et al. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rozen P, Levin B, eds. Prevention and Early Detection of Colorectal Cancer. Philadelphia: Saunders, 1996:21-56.
28. Glick S, Wagner JL, Johnson CD. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. AJR Am J Roentgenol. 1998; 170:629-636.
29. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573-584.
30. SAS Institute Inc. SAS/STAT User's Guide. Version 6. Cary, NC: SAS Institute Inc.; 1990.
31. SAS Institute Inc. SAS/STAT Software: Changes and Enhancements. Release 6.07. Gary, NC: SAS Institute Inc; 1992. SAS Technical Report P-229.
32. Coffield AB, Maciosek MV, McGinnis M, et al. Priorities among recommended clinical preventative services. Am J Prev Med. 2001;21:1-9.